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Study question What are the efficacy 
and safety profiles of standard term 
(12 months) or long term (>12 months) 
dual antiplatelet therapy (DAPT) versus 
short term (<6 months) DAPT after 
percutaneous coronary intervention 
(PCI) with drug eluting stent (DES)? The 
recommended duration of DAPT for 
patients after DES implantation is ≥12 
months for patients with acute coronary 
syndrome and six months for those 
with stable coronary artery disease.
Methods A systematic review and 
network meta-analysis of randomised 
controlled trials comparing two of 
the three durations of DAPT (short 
term, standard term, and long term) 
after PCI with DES was performed. 
The primary study outcomes included 
cardiac or non-cardiac death, all cause 
mortality, myocardial infarction, stent 
thrombosis, and all bleeding events.
Study answer and limitations 
Compared with short term DAPT, 
standard term DAPT had similar 
efficacy and long term DAPT resulted 
in more death and bleeding related 
events. This study is limited to the 
use of aspirin and clopidogrel as 
DAPT. Other P2Y12 receptor inhibitors 
(eg, prasugrel and ticagrelor) were 
not included because of the limited 
number of studies available.
What this study adds Short term 
DAPT should be considered for most 
patients after PCI with DES.
Funding, competing interests, and data 
sharing See bmj.com for funding and 
competing interests. No additional data 
are available.
Study registration PROSPERO 
CRD42018099519.
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The linked study by Richmond and colleagues 
suggests that the risk of breast cancer could be 
causally influenced by a woman’s chronotype, 
as morning types (popularly known as larks) 
were found to have a lower risk of breast 
cancer than evening types (popularly known 
as owls).1 These findings follow a previous 
study from the same UK cohort, showing 
that morning chronotypes also had lower all 
cause and cardiovascular disease mortality.2 
The flip side of this coin is an increased risk 
of illness for evening types.
By the clock
The discovery of “clock genes” and the 
molecular mechanisms that control circadian 
rhythms3 was followed by a rich body of work 
deciphering circadian function.4 This work 
established that our endogenous circadian 
system is highly pervasive and linked to 
fundamental processes such as metabolism, 
cell physiology, and cell growth. Chronotype, 
or diurnal preference, which refers to the 
preferred timing of certain activities (most 
notably, sleeping and wakefulness), is a core 
human trait that is also governed by this 
endogenous circadian clock.
Richmond and colleagues' findings 
should be interpreted within the context 
of externally imposed timings of work and 
social activities—people with the greatest 
mismatch between internal physiological 
timing and external societal demands are at 
risk of circadian misalignment. 
For example, night shift work is one of the 
gravest external stresses on the circadian 
clock. Night shifts necessitate profound 
changes to the timing of behaviours such as 
eating and sleeping, resulting in circadian 
disruption or misalignment and associated 
symptoms (most commonly insomnia) that 
are often referred to as “shift work disorder.” 
Chronic exposure to circadian disruption 
adversely affects long term health, 
increasing the risk of death from major 
causes, including cardiometabolic disease 
and cancer, particularly breast cancer.5‑9
Night work alters the circadian clock’s 
primary output—melatonin rhythms—
most seriously when working hours are 
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Study question Do sleep traits causally 
influence the risk of breast cancer?
Methods Using observational and genetic data 
on 156 848 women enrolled with the UK Biobank 
project, and genetic data on 228 951 women 
who were part of a genome-wide association 
study of breast cancer conducted by the Breast 
Cancer Association Consortium (BCAC), the 
authors investigated whether self reported 
chronotype (morning or evening preference), 
insomnia symptoms, and sleep duration have 
a causal influence on breast cancer risk. The 
study used mendelian randomisation, whereby 
genetic variants associated with possible 
risk factors, such as sleep traits, are used to 
investigate whether these factors are involved 
in causing diseases, such as breast cancer. 
Study answer and limitations In observational 
analysis in the UK Biobank, morning preference 
was inversely associated with risk of breast 
cancer (hazard ratio 0.95, 95% confidence 
interval 0.93 to 0.98 per category increase 
on a five category scale from definite evening 
preference to definite morning preference). 
Mendelian randomisation analysis provided 
supportive evidence for a protective effect of 
morning preference in UK Biobank (hazard 
ratio 0.85, 95% confidence interval 0.70 to 
1.03 per category increase) and BCAC (odds 
ratio 0.88, 95% confidence interval 0.82 to 
0.93 per category increase). In BCAC, there 
was also some evidence for an adverse effect 
of increased sleep duration (odds ratio 1.19, 
95% confidence interval 1.02 to 1.39 per 
hour increase). This study did not, however, 
investigate the potential biological processes 
underlying the observed effects. 
What this study adds Findings showed 
consistent evidence for a protective effect of 
morning preference and suggestive evidence 
for an adverse effect of increased sleep 
duration on breast cancer risk. 
Funding, competing interests, and data sharing 
This study was supported by the Medical Research 
Council (MM_UU_00011, MR/M005070/1), NIHR 
Bristol Biomedical Research Centre, Cancer Research 
UK (C18281/A19169), Economic and Social Research 
Council (ES/N000498/1), European Research Council 
(323195:GLUCOSEGENES-FP7-IDEAS-ERC), and 
Wellcome Trust (WT097835MF). The authors declare 
no financial relationships that could appear to have 
influenced the submitted work. Statistical code is 
available on GitHub (https://github.com/rcrichmond/
sleep_breastcancer_mr/) and from the corresponding 
author (rebecca.richmond@bristol.ac.uk).
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mismatched with preferred sleep timing: 
morning people working night shifts, or 
evening people working morning shifts.10 
Observational studies suggest that morning 
types (unlike evening types) have an 
increased risk of type 2 diabetes if they work 
night shift schedules,11 providing additional 
support for the biological importance of 
circadian misalignment.
The link between chronotype and breast 
cancer risk in Richmond and colleagues' 
study was no longer detectable when 
chronotype was assigned using accelerometer 
derived measures for “timing of the least 
active five hours (L5)” to reflect actual sleep‑
wake activity. The authors did not explore 
the effects on breast cancer risk of any 
mismatch between actual (L5) and preferred 
(self reported) timing of sleep, and further 
research is required to distinguish more 
clearly between the effects of chronotype 
and the effects of circadian misalignment.
Tolerance
How people cope with, and tolerate, shift 
work is highly variable. Some seem to adapt 
well without major adverse consequences,12  
whereas others develop health and 
psychosocial problems when chronically 
exposed to shift work. Tolerance of shift 
work has previously been associated with 
a diurnal preference that favours evenings 
and with other specific behavioural and 
biological phenotypes.13 A new concept of  
“clock resilience” might extend the idea  
of shift work tolerance to include additional 
traits such as sensitivity to seasonal 
changes and psychological concepts  
of resilience and neuroticism, creating 
a more refined clock related phenotype 
associated with poor health outcomes.
Ultimately, the provocative findings of 
Richmond and colleagues identify a need for 
future research exploring how the stresses on 
our biological clock can be reduced. This offers 
a tremendous opportunity for preserving 
good health, achieving healthy aging, 
and, more specifically, for developing new 
personalised strategies for reducing the risk of 
chronic diseases associated with the circadian 
system. In addition to testing interventions 
aiming to modify diurnal preference, this 
line of research could also help to align 
working hours with chronotype—to match 
more closely externally imposed timing with 
individual diurnal preference, especially in 
the working population.
Cite this as: BMJ 2019;365:l4267
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Forest plot of multivariable and mendelian randomisation (MR) estimates for association between sleep traits and breast cancer risk. Odds ratios 
are per category increase in chronotype (from definite evening, intermediate evening, neither, intermediate morning, definite morning), per hour 
increase in sleep duration, and per category increase in insomnia risk (from no, some, and frequent insomnia symptoms). Odds ratios rather 
than hazard ratios for incident breast cancer are shown for multivariable and one sample MR analysis to compare estimates across methods
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Study question What are the associations of 
baseline and long term changes in physical 
activity on mortality?
Methods A UK population based cohort 
study of 14 599 men and women (aged 
40 to 79) was conducted. Physical activity 
energy expenditure (PAEE, in kJ/kg/day) 
was derived from questionnaires and 
calibrated against objective measurements 
from combined movement and heart 
rate monitoring. Survival analysis was 
conducted with multivariable adjustments 
for sociodemographics, medical history, diet 
quality, body mass index, blood pressure, 
and lipids.
Study answer and limitations After 
controlling for baseline physical activity 
and established risk factors, the hazard 
ratio for all cause mortality was 0.76 (95% 
confidence interval 0.71 to 0.82) for each 1 
kJ/kg/day/year increase in physical activity 
(an equivalent trajectory of being inactive 
at baseline and gradually, over five years, 
achieving the World Health Organization 
minimum recommendations of 150 minutes 
per week of moderate intensity physical 
activity). Joint analyses with baseline and 
long term physical activity trajectories show 
that, compared with consistently inactive 
individuals, those with increasing physical 
activity trajectories experienced lower risks 
of mortality, with hazard ratios of 0.76 
(0.65 to 0.88), 0.62 (0.53 to 0.72), and 
0.58 (0.43 to 0.78) at low, medium, and 
high baseline activity, respectively. At the 
population level, meeting and maintaining 
the recommended minimum level of physical 
activity can potentially prevent 46% of 
deaths attributable to physical inactivity. As 
the study was observational, some residual 
confounding cannot be excluded.
What this study adds Middle aged and older 
adults, including those with cardiovascular 
disease and cancer, can gain substantial 
longevity benefits by becoming more 
physically active, regardless of past 
physical activity levels and changes in diet, 
bodyweight, blood pressure, triglycerides, 
and cholesterol.
Funding, competing interests, and data sharing. 
See bmj.com for funding. The authors have no 
competing interests. No additional data are available.
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